Pressing Pause on Psychedelic Cash

Analysing the Challenges in Psychedelic Drug Development Through Investment Trends

Adrienne Rivlin

Read more

Related Insights

Executive Insights

Healthcare Services

A View Into the Promise of Continuous Manufacturing

June 30, 2025

Executive Insights

Life Sciences & Pharma

From Bench to Bedside: Academic-to-Industry Translation in European Biopharma

June 25, 2025

Video / Webinar

Life Sciences & Pharma

Why Health Equity Matters in Pharma

June 12, 2025

Life Sciences & Pharma

Global Manufacturing Footprint Rationalization for a Leading Biopharmaceutical Company

March 31, 2025

A leading biopharmaceutical company engaged L.E.K. Consulting to optimize its global manufacturing network. The client sought to reduce costs while…

Private Equity

Future Ready: Comprehensive Operational Due Diligence on a Medtech and Life Sciences…

February 24, 2025

A private equity firm approached L.E.K. Consulting to conduct operational due diligence on a promising precision medtech and life sciences engineering…

Life Sciences & Pharma

Look Forward 2025: Proving AI’s Value in Life Sciences

January 22, 2025